EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Complement Factor B (CFB) inhibits the malignant progression of lung adenocarcinoma by downregulating the Ras/MAPK signaling pathway

ChengLu He, Xiao Wang, Bo Jiang, Min Zhu, Hui Zhang, Yong Duan, Ya Li

Archives of Biochemistry and Biophysics · 2024

DOI: 10.1016/j.abb.2024.110130 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2024. Verfasst von ChengLu He und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, The First Affiliated Hospital of Kunming Medical University, Kunming, 650032, Yunnan, China; Yunnan Key Laboratory…. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Lung Neoplasms, Down-Regulation, MAP Kinase Signaling System. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung adenocarcinoma (LUAC) as the most common lung cancer, and its incidence is increasing. Complement factor B (CFB) is an important factor in the alternative complement pathway. CFB has been reported to be involved in the progression of many cancers, including in pancreatic cancer, cutaneous squamous cell carcinoma, and nasopharyngeal carcinoma, but the function and molecular mechanism of CFB in LUAC remains unclear. The present study aimed to explore the role of CFB in LUAC malignant progression. In our previous study, we found that CFB was downregulated expression in LUAC clinical samples. Here, we firstly detected the cell function in vitro. Cell proliferation and migration were increased, while cell apoptosis and cell cycle arrest were suppressed after CFB knockdown. Overexpression of CFB repressed the malignant progression of LUAC in vitro. Besides, in vivo experiments revealed that upregulation of CFB inhibited tumor growth and Ki67 expression. Additionally, our data indicated that CFB negatively regulated Ras/mitogen-activated protein kinase (MAPK) signaling pathway. Furthermore, upregulation of CFB inhibited the progression of LUAC was reversed by Ras/MAPK pathway activators (ML-098 or C16-PAF). Our study uncovered that CFB acts as a tumor suppressor repressed tumorigenesis of LUAC through inhibiting the Ras/MAPK pathway, suggesting that CFB may be a potential biomarker and therapeutic target for LUAC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma of LungLung NeoplasmsDown-RegulationMAP Kinase Signaling SystemCell ProliferationComplement Factor BHumansAnimalsras ProteinsMice, NudeDisease ProgressionMiceCell Line, TumorApoptosisCell MovementMice, Inbred BALB CGene Expression Regulation, NeoplasticMaleFemale

Stichwörter der Autor:innen

Complement factor BLung adenocarcinomaRas/MAPK

Substanzen

Complement Factor Bras Proteins

Autor:innen und Institutionen

  • Department of Clinical Laboratory, The First Affiliated Hospital of Kunming Medical University, Kunming, 650032, Yunnan, China; Yunnan Key Laboratory of Laboratory Medicine, Kunming, 650032, Yunnan, China; Yunnan Provin…

Zitieren

APA

He, C., Wang, X., Jiang, B., Zhu, M., Zhang, H., Duan, Y., & Li, Y. (2024). Complement Factor B (CFB) inhibits the malignant progression of lung adenocarcinoma by downregulating the Ras/MAPK signaling pathway. Archives of Biochemistry and Biophysics. https://doi.org/10.1016/j.abb.2024.110130

Vancouver

He C, Wang X, Jiang B, Zhu M, Zhang H, Duan Y, et al. Complement Factor B (CFB) inhibits the malignant progression of lung adenocarcinoma by downregulating the Ras/MAPK signaling pathway. Archives of Biochemistry and Biophysics. 2024. doi:10.1016/j.abb.2024.110130

BibTeX
@article{He2024,
  author = {He, ChengLu and Wang, Xiao and Jiang, Bo and Zhu, Min and Zhang, Hui and Duan, Yong and Li, Ya},
  title = {Complement Factor B (CFB) inhibits the malignant progression of lung adenocarcinoma by downregulating the Ras/MAPK signaling pathway},
  journal = {Archives of Biochemistry and Biophysics},
  year = {2024},
  doi = {10.1016/j.abb.2024.110130}
}
Kostenlos starten →